|
Delayed
TEL AVIV STOCK EXCHANGE
16:33:41 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1,345.00 ILa | +0.45% |
|
-5.35% | -16.87% |
| 09-09 | InterCure Regains Nasdaq Compliance | MT |
| 08-25 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Farming
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 50.77M | - | - | - | - | - |
| 115B | |||||
| 100B | |||||
| 61.18B | - | ||||
| 29.09B | |||||
| 29.25B |
- Stock Market
- Stocks
- INCR Stock
- Charts InterCure Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
